NewAmsterdam Pharma Co. NV (NAMS)
36.17
+0.56
(+1.57%)
USD |
NASDAQ |
Dec 11, 16:00
36.20
+0.04
(+0.10%)
After-Hours: 20:00
NewAmsterdam Pharma Total Assets (Quarterly): 786.43M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| uniQure NV | 888.38M |
| ProQR Therapeutics NV | 146.11M |
| Merus NV | 904.20M |
| argenx SE | -- |
| Pharming Group NV | 473.78M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 58.36M |
| Shareholders Equity (Quarterly) | 728.07M |
| Debt to Equity Ratio | 0.0004 |
| Current Ratio | 12.57 |
| Net Debt Paydown Yield | 0.00% |